Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease

Neuroscience
M OchiH Kase

Abstract

A target neuron of adenosine A(2A) receptor antagonists to exert anti-parkinsonian activities has been currently identified to be, at least in part, striatopallidal medium spiny neurons (MSNs). In the present study, we determine whether A(2A) receptor-mediated modulation is associated with changes in the release of GABA and glutamate in the substantia nigra pars reticulata (SNr), an output structure of the whole basal ganglia network, using in vivo microdialysis in a rat Parkinson's disease (PD) model. In 6-hydroxydopamine (OHDA)-lesioned rats compared with normal rats, basal extracellular GABA levels in the SNr show no change, whereas basal glutamate levels are significantly increased. Oral administration of the A(2A) receptor-selective antagonist (E-1,3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1-H-purine-2,6-dion (KW-6002) to 6-OHDA-lesioned rats at 1 mg/kg caused a marked and sustained increase of GABA and glutamate levels in the SNr. The increase of nigral glutamate by KW-6002 was abolished by a kainic acid-induced lesion of the globus pallidus (GP) or subthalamic nucleus (STN) in 6-OHDA-lesioned rats, whereas the increase of nigral GABA was completely blocked by the GP-lesion but only partially blocked by the S...Continue Reading

References

Oct 1, 1989·Trends in Neurosciences·R L AlbinJ B Penney
Aug 13, 2003·Neurology·W Bara-JimenezT N Chase
Aug 13, 2003·Neurology·Robert A HauserUNKNOWN Istradefylline US-001 Study Group

❮ Previous
Next ❯

Citations

May 16, 2012·Current Neurology and Neuroscience Reports·Patrick Hickey, Mark Stacy
May 24, 2013·Drugs·Rosselle Dungo, Emma D Deeks
Dec 3, 2015·Expert Review of Neurotherapeutics·Ruxandra Julia Vorovenci, Angelo Antonini
Jul 12, 2005·Expert Opinion on Investigational Drugs·Peter Jenner
Feb 9, 2010·Experimental Neurology·Adriana GalvanThomas Wichmann
Oct 4, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Robert A HauserUNKNOWN Istradefylline 6002-US-013 Study Group
Mar 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Jordi Gomez-RamirezJonathan M Brotchie
Apr 8, 2010·CNS Neuroscience & Therapeutics·Deranda B LesterCharles D Blaha
Mar 2, 2005·Pharmacology & Therapeutics·Kui XuMichael Schwarzschild
Sep 1, 2007·Current Therapeutic Research, Clinical and Experimental·John DecerceNeil M Sussman
Jul 9, 2016·Progress in Neurobiology·Philippe De DeurwaerdèreMark J Millan
Jan 23, 2013·Neurobiology of Disease·Chang-Hyun SongH A Jinnah
Aug 4, 2012·Trends in Neurosciences·Aryn H Gittis, Anatol C Kreitzer
Feb 6, 2018·Journal of Neural Transmission·Annalisa PinnaNicola Simola
Aug 8, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Stephen D Aradi, Robert A Hauser
Jan 29, 2021·Expert Review of Neurotherapeutics·Peter JennerRobert A Hauser
Dec 23, 2020·Parkinsonism & Related Disorders·Annalisa PinnaMicaela Morelli
Dec 23, 2020·Parkinsonism & Related Disorders·Akihisa Mori
Jan 11, 2017·ACS Chemical Neuroscience·Michael D NguyenB Jill Venton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.